These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15769961)

  • 1. Estrogen plus progestin and risk of venous thrombosis.
    Scarabin PY; Oger E; Simon T; Plu-Bureau G
    JAMA; 2005 Mar; 293(11):1322; author reply 1322-3. PubMed ID: 15769961
    [No Abstract]   [Full Text] [Related]  

  • 2. Estrogen plus progestin and risk of venous thrombosis.
    Blackwell RE
    JAMA; 2005 Mar; 293(11):1322; author reply 1322-3. PubMed ID: 15769960
    [No Abstract]   [Full Text] [Related]  

  • 3. Estrogen plus progestin and risk of venous thrombosis.
    Cushman M; Kuller LH; Prentice R; Rodabough RJ; Psaty BM; Stafford RS; Sidney S; Rosendaal FR;
    JAMA; 2004 Oct; 292(13):1573-80. PubMed ID: 15467059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Summaries for patients: The effect of estrogen plus progestin on coronary heart disease.
    Ann Intern Med; 2010 Feb; 152(4):I-40. PubMed ID: 20157120
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Estrogen plus progestin therapy and breast cancer in recently postmenopausal women.
    Langer RD
    Am J Epidemiol; 2009 Mar; 169(6):784-5; author reply 785-6. PubMed ID: 19208722
    [No Abstract]   [Full Text] [Related]  

  • 7. Progesterone and Synthetic Progestin Controversies.
    Gompel A; Plu-Bureau G
    JAMA Oncol; 2015 Oct; 1(7):987. PubMed ID: 26448287
    [No Abstract]   [Full Text] [Related]  

  • 8. Progesterone and Synthetic Progestin Controversies.
    Jordan VC; Maximov PY; Fan P
    JAMA Oncol; 2015 Oct; 1(7):986-7. PubMed ID: 26448286
    [No Abstract]   [Full Text] [Related]  

  • 9. Progesterone and Synthetic Progestin Controversies--Reply.
    Joshi PA; Goodwin PJ; Khokha R
    JAMA Oncol; 2015 Oct; 1(7):987-8. PubMed ID: 26448288
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of estrogen plus progestin therapy for prevention.
    Fletcher SW; Colditz GA
    JAMA; 2002 Jul; 288(3):366-8. PubMed ID: 12117403
    [No Abstract]   [Full Text] [Related]  

  • 12. The estrogen and progestin dilemma: new advice, labeling guidelines.
    Bren L
    FDA Consum; 2003; 37(2):10-1. PubMed ID: 12715763
    [No Abstract]   [Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 420, November 2008: hormone therapy and heart disease.
    American College of Obstetricians and Gynecologists Committee on Gynecologic Practice
    Obstet Gynecol; 2008 Nov; 112(5):1189-92. PubMed ID: 18978127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous HRT with oestrogen plus progestogen is linked to reduced risk of endometrial cancer.
    Mayor S
    BMJ; 2015 Dec; 351():h6627. PubMed ID: 26645093
    [No Abstract]   [Full Text] [Related]  

  • 15. Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Weiss NS; Larson EB; Rosendaal FR; Psaty BM
    JAMA; 2004 Oct; 292(13):1581-7. PubMed ID: 15467060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy. A year in review.
    Mayo Clin Womens Healthsource; 2003 Aug; 7(8):1-2. PubMed ID: 12925832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormones: where do we go from here?
    Harv Womens Health Watch; 2003 Jan; 10(5):3-4. PubMed ID: 12543588
    [No Abstract]   [Full Text] [Related]  

  • 19. [Requiem for hormone replacement therapy? This does not apply to modern preparations!].
    Lippert TH; Mueck AO
    MMW Fortschr Med; 2003 Sep; 145(37):13; author reply 13-4. PubMed ID: 14584434
    [No Abstract]   [Full Text] [Related]  

  • 20. Abbreviated hormone replacement therapy trial answers some questions, raises new ones. The Women's Health Initiative is no longer testing the most widely prescribed estrogen and progestin combination--but the study's job is far from over.
    Harv Womens Health Watch; 2002 Oct; 10(2):2-4. PubMed ID: 12393317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.